The multiple sclerosis gut microbiome and disease activity: A systematic review
Abstract
BACKGROUND
The gut microbiome is a potential therapeutic target for multiple sclerosis (MS), yet its association with disease activity remains unclear. We systematically reviewed the literature to investigate the relationship between the gut microbiome and MS disease activity, course, and disability progression.
METHODS
We searched MEDLINE, EMBASE, Web of Science and Google Scholar (01/2011-02/2024) to identify relevant observational or interventional studies published in English. Case reports were ineligible. Outcomes included disease activity (e.g. relapses, MRI), course (e.g. relapsing-remitting/secondary-progressive [RR/SPMS]) and disability progression (e.g. using the Expanded Disability Status Scale [EDSS]). Study quality was evaluated using the Newcastle-Ottawa Scale.
RESULTS
Four longitudinal and nineteen cross-sectional studies were included, totaling 1760 persons with MS. Most were female (1237/1760, 70 %) and had RRMS (1378/1760, 78 %). The majority of studies (67 %;10/15) examining gut diversity (alpha or beta) did not find an association with disease activity, course or progression. However, several gut taxa exhibited significant associations with study outcomes, including eight that varied in consistent directions: a higher abundance of Actinobacteria, Bacteroidota and Roseburia inulinivorans were associated with better MS outcomes (e.g. lower EDSS scores), while higher abundances of Streptococcus, Clostridium nexile, Clostridium scindens and Collinsella…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids
- Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome
- Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
- Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model
- Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
- Glyphosate-based herbicides influence antioxidants, reproductive hormones and gut microbiome but not reproduction: A long-term experiment in an avian model
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.